Drug delivery through intact skin has been around for ages,1 but it’s still far from perfect. A myriad of issues continues to compromise treatment, such as adhesion.2 In addition, many pain management patches only deliver a fraction of the medicine allocated to the patch.3
See how we’re engineering patch systems to efficiently deliver medicine through the skin. Our adhesive and pliable properties are designed to permit reliable skin contact throughout the dosing regimen.
SCILEX employs anhydrous, single-layer, drug-in-adhesive, topical delivery system technology to keep its patches thin and drug delivery locally targeted.
Our patch technology utilizes a proprietary single-layer anhydrous system, allowing it to be cut into smaller sizes.
We’ve structured our patches to be flexible to the contours of the human body.
References: 1. Banerjee S, Chattopadhyay P, Ghosh A, Datta P, Veer V. Aspect of adhesives in transdermal drug delivery systems. Int J Adhes Adhes. 2014;50:70-84. 2. Hughes PJ, Freeman MK, Wensel TM. Appropriate use of transdermal drug delivery systems. J Nurs Educ Pract. 2013;3(10):129-138. 3. Lidoderm [package insert]. Malvern, PA: Endo Pharmaceuticals Inc.; 2015.